ReviewNature reviews. Nephrology2017
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.
Ralph A DeFronzo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
249 papers cite itlatest 60 shown
this paperpooled ittrialcites it